Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

mylan pharmaceuticals inc. - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 5 mg - desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 12 years of age and older. desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions (6.2)] . the limited available data with desloratadine in pregnant women are not sufficient to inform a drug-associated risk for major birth defects and miscarriage. there are no adequate and well-controlled studies in pregnant women. desloratadine given during organogenesis to pregnant rats was not teratoge

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

consilient health ltd - desloratadine - tablet - 5mg

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

actavis uk ltd - desloratadine - tablet - 5mg

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

aspire pharma ltd - desloratadine - tablet - 5mg

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

lupin healthcare (uk - desloratadine - tablet - 5mg

Suurbritannia - inglise - MHRA (Medicines & Healthcare Products Regulatory Agency)

mylan - desloratadine - tablet - 5mg

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

avpak - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 5 mg - desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 12 years of age and older. desloratadine tablets are indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 12 years of age and older. - desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions ( 5.1) and adverse reactions ( 6.2)]. desloratadine tablets are contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions ( 5.1) and adverse reactions ( 6.2)]. pregnancy category c: there are no adequate and well-controlled studies in pregnant

Ameerika Ühendriigid - inglise - NLM (National Library of Medicine)

taro pharmaceuticals u.s.a., inc. - desloratadine (unii: fvf865388r) (desloratadine - unii:fvf865388r) - desloratadine 0.5 mg in 1 ml - desloratadine oral solution is indicated for the relief of the nasal and non-nasal symptoms of seasonal allergic rhinitis in patients 2 years of age and older. desloratadine oral solution is indicated for the relief of the nasal and non-nasal symptoms of perennial allergic rhinitis in patients 6 months of age and older. desloratadine oral solution is indicated for the symptomatic relief of pruritus, reduction in the number of hives, and size of hives, in patients with chronic idiopathic urticaria 6 months of age and older. desloratadine oral solution is contraindicated in patients who are hypersensitive to this medication or to any of its ingredients or to loratadine [see warnings and precautions (5.1) and adverse reactions (6.2)] . pregnancy category c: there are no adequate and well-controlled studies in pregnant women. because animal reproduction studies are not always predictive of human response, desloratadine should be used during pregnancy only if clearly needed. desloratadine was not teratogenic in

Belgia - inglise - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

aurobindo sa-nv - desloratadine 5 mg - film-coated tablet - 5 mg - desloratadine 5 mg - desloratadine

Belgia - inglise - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

eg sa-nv - desloratadine 5 mg - film-coated tablet - 5 mg - desloratadine 5 mg - desloratadine